| Followers | 71 |
| Posts | 9117 |
| Boards Moderated | 0 |
| Alias Born | 03/06/2016 |
Monday, April 28, 2025 4:49:55 PM
I called and sent a text...no answer....
I suspect if true....MHRA rejected and sent it to the CHM to have a go at it...does not bode well and most likely query will go unanswered and we will see the "truth" in a PR shortly (after some addition/significant dilution)....Nemesis may be right after all.
Some may not like what I just said....I am just following the path of least resistance....MHRA caught up + statement that a few objections are handed over to CHM + significant dilution (hedging against CHM approval) + 500 days post submission....470 days since January '24 acceptance + No ASCO (don't want to stand there and admit rejection + my sense is company is not being forthright. If I was running the show, I would want to dilute as much as possible to keep the lights on as long as possible since there are other sticks in the fire....Unfortunately, this year appears dead.
Lord, I hope I am wrong...My gut says be patient for another 18 months.
I suspect if true....MHRA rejected and sent it to the CHM to have a go at it...does not bode well and most likely query will go unanswered and we will see the "truth" in a PR shortly (after some addition/significant dilution)....Nemesis may be right after all.
Some may not like what I just said....I am just following the path of least resistance....MHRA caught up + statement that a few objections are handed over to CHM + significant dilution (hedging against CHM approval) + 500 days post submission....470 days since January '24 acceptance + No ASCO (don't want to stand there and admit rejection + my sense is company is not being forthright. If I was running the show, I would want to dilute as much as possible to keep the lights on as long as possible since there are other sticks in the fire....Unfortunately, this year appears dead.
Lord, I hope I am wrong...My gut says be patient for another 18 months.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
